Cardiovascular disease (CVD) remains a formidable health concern for women, demanding a nuanced understanding of its manifestation, risk factors, and unique challenges in diagnosis and management. While historically considered primarily a male-centric issue, CVD is a leading cause of morbidity and mortality in women globally. The presentation of cardiovascular symptoms in women can differ from the classical patterns observed in men, making diagnosis and timely intervention a complex task. Hormonal fluctuations, particularly during menopause, introduce additional variables influencing cardiovascular health in women. Several risk factors contribute to the development of CVD in women, including age, genetics, hypertension, diabetes, and lifestyle choices. The intricate interplay of these factors underscores the need for tailored preventive strategies and early detection methods. Pregnancy-related complications such as gestational diabetes and hypertensive disorders further amplify cardiovascular risks in women, emphasizing the importance of holistic women's health care. The impact of CVD on women extends beyond the physical realm, affecting their quality of life and socioeconomic well-being. Recognition of gender-specific disparities in access to healthcare and the underrepresentation of women in cardiovascular research underscores the imperative for a gender-sensitive approach in medical research, policy, and clinical practice. Preventive measures encompass lifestyle modifications, including a heart-healthy diet, regular exercise, and stress management. Moreover, addressing risk factors unique to women, such as complications during pregnancy, is pivotal. Empowering women with knowledge about cardiovascular health, fostering awareness, and promoting regular health check-ups contribute to a proactive approach. In conclusion, tackling cardiovascular disease in women requires a comprehensive understanding of its multifaceted nature, gender-specific risk factors, and tailored preventive strategies. By bridging gaps in research, healthcare policies, and public awareness, we can aspire to diminish the burden of cardiovascular disease, enhance women's cardiovascular health, and promote a future where every woman has the tools to safeguard her heart health and overall well-being.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia